342
Participants
Start Date
November 7, 2017
Primary Completion Date
May 17, 2019
Study Completion Date
May 17, 2019
M207 Microneedle System
M207 Microneedle System 3.8 mg
Rochester Clinical Research, Rochester
Thomas Jefferson University, Philadelphia
Peters Medical Research, High Point
North Carolina Clinical Research, Raleigh
Raleigh Medical Group PMG Research, Raleigh
Coastal Carolina Research Center, Mt. Pleasant
Primary Care Associates/Radiant Research, Anderson
Harmony Medical Research Institute, Hialeah
Achieve Clinical Research, Birmingham
Michigan Headache and Neurological Institute, Ann Arbor
Clinical Research Institute, Minneapolis
Clinical Research Institute, Plymouth
Lillestol Research, Fargo
Clinvest Research, Springfield
DelRicht Research, New Orleans
University of Texas Southwestern Medical Center - Neurology Clinic, Dallas
Central Texas Health Research, New Braunfels
FutureSearch Trials of Neurology, Austin
Colorado Allergy Asthma Centers, Denver
Advanced Clinical Research, Meridian
Elite Clinical Studies, Phoenix
Albuquerque Clinical Trials, Albuquerque
Downtown L.A. Research Center, Los Angeles
California Medical Clinic for Headache, Santa Monica
Empire Clinical Research, Upland
Stanford University Medical Center, Palo Alto
Allergy Asthma Associates of Santa Clara Valley Research Center, San Jose
Boston Clinical Trials, Boston
MedVadis Research Corporation, Watertown
StudyMetrix Research LLC, City of Saint Peters
Dartmouth-Hitchcock Medical Center, Lebanon
Zosano Pharma Corporation
INDUSTRY